{
  "pmcid": "11363871",
  "sha256": "655a9b67ef405915a441e84224871f395b54ec23744e8420622ad15be5166758",
  "timestamp_utc": "2025-11-09T23:15:27.477938+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 10.006654135338348,
    "reading_ease": 49.56781954887222,
    "word_count": 280
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Tailoring Biliopancreatic Limb Length in One Anastomosis Gastric Bypass: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "randomised intraoperatively"
      },
      "Participants": {
        "score": 2,
        "evidence": "eligible patients aged 18-65 years, meeting IFSO criteria for metabolic bariatric surgery, were randomised intraoperatively"
      },
      "Intervention": {
        "score": 2,
        "evidence": "The intervention group received a tailored BP limb based on TSBL, while the control group received a standard 150 cm BP limb."
      },
      "Objective": {
        "score": 1,
        "evidence": "aimed to evaluate whether tailoring the biliopancreatic (BP) limb length based on total small bowel length (TSBL) results in superior outcomes compared to a fixed 150 cm BP limb in one anastomosis gastric bypass (OAGB)."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was percentage total weight loss (%TWL) at 5 years, with a predefined 1-year analysis."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation used a sealed envelope method with allocation concealment."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Patients, research team, and care providers were blinded."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Between September 2020 and August 2022, 212 patients were randomised: 105 to the standard group and 107 to the tailored group."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "At 1 year, the mean %TWL was 32.8% in the standard group and 33.1% in the tailored group (P = 0.787)."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "At 1 year, the mean %TWL was 32.8% in the standard group and 33.1% in the tailored group (P = 0.787)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were mild and occurred in 3% of the intervention group and 1% of the control group."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: Dutch Trial Register, NL7945."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 21,
    "max_score": 25
  }
}